Buy The Rumour Sell The News
MGRM, no reaction from investors over the PFE positive results from FDA. Investors were not impressed of Maraviroc suspected to be no safety and risks to the patients. There are many better products available in the market compared to Maraviroc. MGRM share rallied from 2.19 to 2.45 minutes before the news is published in media. The rally last for 2 to 3 minutes, the share of MGRM went down as low as 2.10. It was pure manipulation by MMs and insiders.
Imagine, there were more than 5 millions of MGRM shares within 2 to 3 minutes. I bought MGRM 2K earlier at 2.16 before the news and was ready to push the button to execute sell order. I also observed Poem on Line status shown, buy 2.18 and sell 2.19 and was not flicking at all, whilst Alphatrade, buy 2.38 and sell 2.39. It was shocking to see that Poem server could not update real time update of buy and sell price whenever there was a big volume buy and sell transaction took place. Whilst I was trying to figure out why such thing could happened, MGRM price already down to 2.29. I immediately keyed in the sell order at 2.20 knowing that it was selling pressure, and my sell order done at 2.20.
The real story of the above is that, we can’t rely on Poem on line as it is 1 to 2 minutes delay compared to Alphatrade real time.
ONT, closed at 2.48 and went down to 2.27 after hours after the management announced of the share placement offered by the company to one of the institutional funds. I sold 1K of ONT at 2.30.
VION, I will be monitoring this counter tonight and will post later tonight the company fundamental and their future growth.
Yesterday transaction
MGRM Bought 3K – sold 1K 2.29 and 2K 2.20
ONT Bought 1K 2.21 – sold 1K 2.30
DNDN Bought 300 shares 16.70 – sold 300 shares 16.85
7 comments:
Those counters that we monitor today lack of direction. I see Bio-stocks still had the attention - sell -off.
I do not know whether MGRM support at 2.00 can hold. Next support at 1.90
VION too, hammered by shortist, but I think the other support 1.96 will hold. Insiders bought at 1.85.
Buy the rumors sell the facts.
News already out and their products can't compete with promising SGP product.
Sorry, the strong support at 1.86
I missed DNDN at 16.60 just now, already up 17.40 now.
The problem with stock below 5.00, once there is no more buying interest, the price go down all the way and hard to recover.
Morsid, click on the video link
Dendreon “market outperform,” target price raised - update
I bough CVTX 400 shares @ 8.50
First Albany upgraded CV Therapeutics (nasdaq: CVTX - news - people ) to "buy" from "neutral." The biotech narrowed its first-quarter loss to $70 million. Revenue jumped on sales of its chronic angina drug Ranexa.
morsid, are u still around
Post a Comment